2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
作者信息
Heidenreich Paul A, Fonarow Gregg C, Breathett Khadijah, Jurgens Corrine Y, Pisani Barbara A, Pozehl Bunny J, Spertus John A, Taylor Kenneth G, Thibodeau Jennifer T, Yancy Clyde W, Ziaeian Boback
出版信息
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099. doi: 10.1161/HCQ.0000000000000099. Epub 2020 Nov 2.
Abstract
摘要
相似文献
1
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099. doi: 10.1161/HCQ.0000000000000099. Epub 2020 Nov 2.
2
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e000132. doi: 10.1161/HCQ.0000000000000132. Epub 2024 Aug 8.
3
2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000037. doi: 10.1161/HCQ.0000000000000037.
4
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.
Circulation. 2012 May 15;125(19):2382-401. doi: 10.1161/CIR.0b013e3182507bec. Epub 2012 Apr 23.
5
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.
J Am Coll Cardiol. 2012 May 15;59(20):1812-32. doi: 10.1016/j.jacc.2012.03.013. Epub 2012 Apr 23.
6
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). doi: 10.1161/HCQ.0000000000000032.
7
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e000057. doi: 10.1161/HCQ.0000000000000057. Epub 2019 Nov 12.
8
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
J Am Coll Cardiol. 2020 Nov 24;76(21):2527-2564. doi: 10.1016/j.jacc.2020.07.023. Epub 2020 Nov 2.
9
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.
J Am Coll Cardiol. 2024 Sep 17;84(12):1123-1143. doi: 10.1016/j.jacc.2024.05.014. Epub 2024 Aug 8.
10
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.
引用本文的文献
1
Feasibility and Safety of Early Cardiac Rehabilitation Using Remote Electrocardiogram Monitoring in Patients with Cardiac Surgery: A Pilot Study.
J Clin Med. 2025 Jul 10;14(14):4887. doi: 10.3390/jcm14144887.
2
Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure.
JACC Adv. 2024 Sep 7;3(10):101250. doi: 10.1016/j.jacadv.2024.101250. eCollection 2024 Oct.
3
Future of Patient-Reported Outcomes: Bringing Patients' Voices Into Health Care.
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e010008. doi: 10.1161/CIRCOUTCOMES.124.010008. Epub 2024 Sep 17.
4
Optimization of Guideline-Directed Medical Therapy During Hospitalization for Heart Failure: Mind the Gap!
JACC Adv. 2024 Feb 14;3(7):100819. doi: 10.1016/j.jacadv.2023.100819. eCollection 2024 Jul.
5
Burden from Study Questionnaire on Patient Fatigue in Qualitative Congestive Heart Failure Research.
J Cardiovasc Dev Dis. 2024 Mar 24;11(4):96. doi: 10.3390/jcdd11040096.
6
Development of delivery indicators and delivery enablers for cardiovascular disease in the UK: a modified Delphi study.
BMJ Open Qual. 2024 Feb 26;13(1):e002634. doi: 10.1136/bmjoq-2023-002634.
7
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.
Clin Cardiol. 2024 Feb;47(2):e24233. doi: 10.1002/clc.24233.
8
Acceptability of a Text Message-Based Mobile Health Intervention to Promote Physical Activity in Cardiac Rehabilitation Enrollees: A Qualitative Substudy of Participant Perspectives.
J Am Heart Assoc. 2024 Jan 16;13(2):e030807. doi: 10.1161/JAHA.123.030807.
9
Challenges of Health Data Use in Multidisciplinary Chronic Disease Care: Perspective from Heart Failure Care.
J Cardiovasc Dev Dis. 2023 Dec 5;10(12):486. doi: 10.3390/jcdd10120486.
10
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction.
Am Heart J Plus. 2022 Jul;19. doi: 10.1016/j.ahjo.2022.100186.
本文引用的文献
1
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail. 2020 Jan;8(1):43-54. doi: 10.1016/j.jchf.2019.08.003. Epub 2019 Dec 11.
2
Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
JACC Heart Fail. 2019 Aug;7(8):691-705. doi: 10.1016/j.jchf.2019.04.023. Epub 2019 Jul 10.
3
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.
JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.
4
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
Circulation. 2019 May 7;139(19):2285-2288. doi: 10.1161/CIRCULATIONAHA.118.039331.
5
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
J Am Coll Cardiol. 2019 May 21;73(19):2365-2383. doi: 10.1016/j.jacc.2019.02.015. Epub 2019 Mar 4.
6
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
7
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.
Int J Cardiol. 2018 Dec 15;273:141-146. doi: 10.1016/j.ijcard.2018.08.012. Epub 2018 Aug 6.
8
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.
9
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.
JACC Heart Fail. 2018 Jun;6(6):465-473. doi: 10.1016/j.jchf.2018.02.002.
10
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004668. doi: 10.1161/CIRCOUTCOMES.118.004668.
Zotero 插件